Windgap Medical – making progress toward an alternative to the EpiPen
Windgap Medical is moving forward in its development of its EpiPen alternative device with two newly solidified patents.
Windgap Medical is moving forward in its development of its EpiPen alternative device with two newly solidified patents.
A lot of bases in healthcare innovation were covered at CONVERGE this week. We'll reflect back on some highlights.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
There must be some better, more efficient solutions for the essential use of the EpiPen, and Windgap Medical is working on it.
Check out Friday's MedHeads and catch up on the top stories of the week.
As allergies rise, so does the need for on-the-spot epinephrine treatment. Windgap Medical wants to win a chunk of this fast-growing, $1.3 billion market.